EAGAN, MN / ACCESSWIRE / November 19, 2020 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation participated in the Canaccord 2020 Medical Technologies & Diagnostics Forum, that was held virtually today. John Krier, Chief Executive Officer and members of the Company’s leadership team provided an update to investors including a discussion of recently announced structural changes and the Company’s plans for pursuing future growth opportunities. All meetings were held in a 1-on-1 format.
“We were excited to participate in the Canaccord Forum to share our story and early results from our emerging, scalable business model,” explained Krier.
Investors are encouraged to access our updated investor presentation on the investor relations portion of our website at https://irdirect.net/dynt or alternatively request a copy of the presentation from Peter Seltzberg or Skyler Black.
About Dynatronics Corporation
Dynatronics is a leading medical device company committed to providing high-quality restorative products designed to accelerate achieving optimal health. The Company designs, manufactures, and sells a broad range of products for clinical use in physical therapy, rehabilitation, pain management, and athletic training. Through its distribution channels, Dynatronics markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and consumers. The Company’s products are marketed under a portfolio of high-quality, well-known industry brands including Bird & Cronin®, Solaris™, Hausmann™, Physician’s Choice®, and PROTEAM™, among others. More information is available at www.dynatronics.com.
CONTACT:
Dynatronics Corporation
Investor Relations
Skyler Black
(801) 676-7201
skyler.black@dynatronics.com
Darrow Associates, Inc.
Peter Seltzberg, Managing Director
Investor Relations
(516) 419-9915
pseltzberg@darrowir.com
For additional information, please visit: www.dynatronics.com
Connect with Dynatronics on LinkedIn
SOURCE: Dynatronics Corporation
View source version on accesswire.com:
https://www.accesswire.com/617655/Dynatronics-Corporation-Participates-in-Canaccord-Genuity-2020-Medical-Technologies-Diagnostics-Forum
Atopic dermatitis is a chronic disease that disproportionately impacts communities of color Dupixent achieved 75%…
Digital health platform offers FDA-approved treatments when appropriate and personalized care plans through licensed providers.New…
NSCEB is launching a 3-month tour of the booming U.S. biotechnology ecosystem RALEIGH, N.C., June…
MDP Completes Acquisition of Significant Ownership Position in NextGen Healthcare and Partners with Thoma Bravo…
New resource helps healthcare providers improve branded communication, ensure HIPAA compliance, and boost patient engagement…
TEMPE, Ariz., June 6, 2025 /PRNewswire/ -- Economic activity in the hospital subsector expanded in…
![](data:image/svg+xml;charset=utf-8,<svg height="32px" width="32px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="400px" width="600px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
